XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive loss were as follows (in thousands):
September 30,
2022
December 31,
2021
Foreign currency translation adjustment$(46,627)$(5,758)
Total accumulated other comprehensive loss$(46,627)$(5,758)
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Share
The following table sets forth the calculation of basic and diluted net income per share (in thousands, except per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,

Numerator:
2022202120222021
Net income
$72,290 $64,304 $245,081 $199,664 
Denominator:
Denominator for basic net income per share — weighted-average outstanding shares
394,712 392,419 393,650 392,101 
Effect of dilutive securities:
Stock options, restricted stock awards and restricted stock units
1,497 1,876 1,323 1,935 
Denominator for diluted net income per share — weighted-average outstanding shares
396,209 394,295 394,973 394,036 
 
Net income per share — basic
$0.18 $0.16 $0.62 $0.51 
Net income per share — diluted
$0.18 $0.16 $0.62 $0.51 
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes the shares underlying the unvested performance-based restricted stock and anti-dilutive securities excluded from the basic and diluted earnings per share calculations (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Performance-based restricted stock awards
621 718 621 718 
Anti-dilutive securities
748 192 1,144 433 
Schedule of Stock-based Compensation Expense for Stock Options and Restricted Stock
Stock-based compensation expense for stock options, restricted stock awards and restricted stock units issued under equity incentive plans, stock purchases under the Employee Stock Purchase Plan, Deferred Stock Units and Matching RSUs awarded under the Company's MSPP included in the Company’s statements of operations were as follows (in thousands):

Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Cost of revenues$3,041 $2,835 $9,002 $8,283 
Selling and marketing (excluding customer base amortization)1,957 1,620 5,605 4,644 
Software development3,158 3,316 9,262 9,289 
General and administrative9,982 8,528 30,228 24,772 
Total stock-based compensation expense$18,138 $16,299 $54,097 $46,988